Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.850
-0.090 (-4.64%)
Nov 6, 2025, 4:00 PM EST - Market closed
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $3.54 million as of November 7, 2025. Its market cap has decreased by -10.07% in one year.
Market Cap
3.54M
Enterprise Value
2.35M
1-Year Change
-10.07%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since November 14, 2017, Artelo Biosciences's market cap has decreased from $5.88M to $3.54M, a decrease of -39.73%. That is a compound annual growth rate of -6.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 3.54M | 3.50% |
| Dec 31, 2024 | 3.42M | -23.37% |
| Dec 29, 2023 | 4.46M | -45.90% |
| Dec 30, 2022 | 8.25M | -62.41% |
| Dec 31, 2021 | 21.95M | 99.02% |
| Dec 31, 2020 | 11.03M | 19.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |